Jefferies says Otsuka’s wholly owned products mix may lift margins
Jefferies analysts said Otsuka Holdings’ revenue growth from wholly owned products is likely to help boost profitability, citing an improving product mix and margin impact. Consensus may be underestimating the effect.
Jefferies analysts said Otsuka Holdings’ revenue growth from wholly owned products is likely to help boost profitability in a note. S. bank said consensus appears to be underestimating the margin impact of an improving product mix. It cited Voyxact, a kidney disease drug, and other wholly owned assets.